Pearsanta
Healthcare Services · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
737 N 5th St Ste 200, Richmond, Virginia...Phone Number
(888) 234-8980Website
www.pearsanta.comRevenue
$6.5 MillionIndustry
About Pearsanta
Pearsanta Org Chart
Is Pearsanta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Pearsanta, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Pearsanta recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Pearsanta had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Pearsanta has new funding data
Product Launch: Get notified when Pearsanta launches new products
Congratulate Masked Content for being promoted to Masked Content at Pearsanta
Check if Pearsanta has recently received funding, and reach out quickly before it becomes old news!
Check out if Pearsanta is spiking on competitors!
Recommended Actions
Find VP level buyers at Pearsanta
Find 2 more new buyers
Compare Similar Companies to Pearsanta
Compare insights from companies similar to Pearsanta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pearsanta is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Pearsanta is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Pearsanta.
Pearsanta Tech Stack
A closer look at the technologies used by Pearsanta
Most Recent Scoops
Pearsanta News & Media
Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics ...
MOUNTAIN VIEW, Calif., March 24, 2025--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ("Pearsanta"), has acquired key patents related to adductomics-based DNA damage detection, which it believes will further strengthen its position in the cancer prevention-focused diagnostic industry.Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ("Pearsanta"), has acquired key patents related to adductomics-based DNA damage detection, which it believes will further strengthen its position in the cancer prevention-focused diagnostic industry. Pearsanta acquired the patents in exchange for the issuance of Pearsanta ConvAditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. (“Pearsanta”), has engaged Dominari Securities LLC as lead underwriter for Pearsanta’s planned initial public offering (IPO). The proposed IPO, advised by Dominari Securities, is intended to support Pearsanta’s U.S. and international commercial launch efforts andAditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, is pleased to announce that its Board of Directors has authorized management to explore taking its subsidiary, Pearsanta, Inc. (“Pearsanta”), public via a proposed initial public offering (“IPO”) in 2025. This decision aligns with Aditxt's mission to secure and develop transformative health innovations, positioning
Top Healthcare Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Pearsanta
Pearsanta is a medical diagnostic and innovation company that offers personalized, data-driven diagnostic and monitoring solutions tailored to patient demographics, medical history, genetics, and risk factors. The company focuses on biosample collection, processing, and delivering actionable health information through its patented technology and a... Read More